These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 37008904)

  • 1. Epigenetics of methylation modifications in diabetic cardiomyopathy.
    Hao J; Liu Y
    Front Endocrinol (Lausanne); 2023; 14():1119765. PubMed ID: 37008904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetics in diabetic cardiomyopathy.
    Ma X; Mei S; Wuyun Q; Zhou L; Sun D; Yan J
    Clin Epigenetics; 2024 Apr; 16(1):52. PubMed ID: 38581056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetics and diabetic cardiomyopathy.
    Singh GB; Sharma R; Khullar M
    Diabetes Res Clin Pract; 2011 Oct; 94(1):14-21. PubMed ID: 21696841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel insights into DNA methylation and its critical implications in diabetic vascular complications.
    Zheng J; Cheng J; Zhang Q; Xiao X
    Biosci Rep; 2017 Apr; 37(2):. PubMed ID: 28183874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic modifications: An important mechanism in diabetic disturbances.
    Rorbach-Dolata A; Kubis A; Piwowar A
    Postepy Hig Med Dosw (Online); 2017 Nov; 71(0):960-974. PubMed ID: 29225202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting epigenetics in diabetic cardiomyopathy: Therapeutic potential of flavonoids.
    Zhou Y; Suo W; Zhang X; Yang Y; Zhao W; Li H; Ni Q
    Biomed Pharmacother; 2023 Jan; 157():114025. PubMed ID: 36399824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging role of epigenetics and miRNA in diabetic cardiomyopathy.
    Asrih M; Steffens S
    Cardiovasc Pathol; 2013; 22(2):117-25. PubMed ID: 22951386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Histone methylation and diabetic cardiomyopathy].
    Hong H; Li YM; Meng XM; Deng T; Zhu BM
    Sheng Li Xue Bao; 2022 Jun; 74(3):461-468. PubMed ID: 35770643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetics and Cardiovascular Disease in Diabetes.
    Pasquier J; Hoarau-Véchot J; Fakhro K; Rafii A; Abi Khalil C
    Curr Diab Rep; 2015 Dec; 15(12):108. PubMed ID: 26458379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Role of Fibroblast Growth Factor 21 in Diabetic Cardiovascular Complications and Related Epigenetic Mechanisms.
    Xiao M; Tang Y; Wang S; Wang J; Wang J; Guo Y; Zhang J; Gu J
    Front Endocrinol (Lausanne); 2021; 12():598008. PubMed ID: 34349728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unraveling the epigenetic fabric of type 2 diabetes mellitus: pathogenic mechanisms and therapeutic implications.
    Jazieh C; Arabi TZ; Asim Z; Sabbah BN; Alsaud AW; Alkattan K; Yaqinuddin A
    Front Endocrinol (Lausanne); 2024; 15():1295967. PubMed ID: 38323108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic basis of diabetic vasculopathy.
    Bhamidipati T; Kumar M; Verma SS; Mohanty SK; Kacar S; Reese D; Martinez MM; Kamocka MM; Dunn KW; Sen CK; Singh K
    Front Endocrinol (Lausanne); 2022; 13():989844. PubMed ID: 36568089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Machine-learning to stratify diabetic patients using novel cardiac biomarkers and integrative genomics.
    Hathaway QA; Roth SM; Pinti MV; Sprando DC; Kunovac A; Durr AJ; Cook CC; Fink GK; Cheuvront TB; Grossman JH; Aljahli GA; Taylor AD; Giromini AP; Allen JL; Hollander JM
    Cardiovasc Diabetol; 2019 Jun; 18(1):78. PubMed ID: 31185988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-coding RNA-mediated endothelial-to-mesenchymal transition in human diabetic cardiomyopathy, potential regulation by DNA methylation.
    Wang E; Chen S; Wang H; Chen T; Chakrabarti S
    Cardiovasc Diabetol; 2023 Nov; 22(1):303. PubMed ID: 37924123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic mechanisms in diabetic complications and metabolic memory.
    Reddy MA; Zhang E; Natarajan R
    Diabetologia; 2015 Mar; 58(3):443-55. PubMed ID: 25481708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetics of hypertension as a risk factor for the development of coronary artery disease in type 2 diabetes mellitus.
    Karabaeva RZ; Vochshenkova TA; Mussin NM; Albayev RK; Kaliyev AA; Tamadon A
    Front Endocrinol (Lausanne); 2024; 15():1365738. PubMed ID: 38836231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetics: key to improve delayed wound healing in type 2 diabetes.
    Dubey R; Prabhakar PK; Gupta J
    Mol Cell Biochem; 2022 Feb; 477(2):371-383. PubMed ID: 34739665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Noncoding RNAs involved in DNA methylation and histone methylation, and acetylation in diabetic vascular complications.
    Lu J; Huang Y; Zhang X; Xu Y; Nie S
    Pharmacol Res; 2021 Aug; 170():105520. PubMed ID: 33639232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic Modifications Associated with the Pathogenesis of Type 2 Diabetes Mellitus.
    Hossan T; Kundu S; Alam SS; Nagarajan S
    Endocr Metab Immune Disord Drug Targets; 2019; 19(6):775-786. PubMed ID: 30827271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The epigenetic landscape in the cardiovascular complications of diabetes.
    Costantino S; Ambrosini S; Paneni F
    J Endocrinol Invest; 2019 May; 42(5):505-511. PubMed ID: 30291588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.